SC13-0745 Screening compound: N-(1-{[3-(4-fluorophenyl)-1H-pyrazol-4-yl]methyl}piperidin-3-yl)-N-[(pyridin-3-yl)methyl]acetamide

SC13-0745 Screening compound: N-(1-{[3-(4-fluorophenyl)-1H-pyrazol-4-yl]methyl}piperidin-3-yl)-N-[(pyridin-3-yl)methyl]acetamide
SC13-0745 Screening compound: N-(1-{[3-(4-fluorophenyl)-1H-pyrazol-4-yl]methyl}piperidin-3-yl)-N-[(pyridin-3-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound SC13-0745
N-(1-{[3-(4-fluorophenyl)-1H-pyrazol-4-yl]methyl}piperidin-3-yl)-N-[(pyridin-3-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

SC13-0745

Molecular Formula

C23H26FN5O (C23 H26 FN5 O)

Compound Name

N-(1-{[3-(4-fluorophenyl)-1H-pyrazol-4-yl]methyl}piperidin-3-yl)-N-[(pyridin-3-yl)methyl]acetamide

IUPAC name

N-(1-{[3-(4-fluorophenyl)-1H-pyrazol-4-yl]methyl}piperidin-3-yl)-N-[(pyridin-3-yl)methyl]acetamide

SMILES

CC(N(Cc1cnccc1)C1CN(Cc2c[nH]nc2-c(cc2)ccc2F)CCC1)=O

InChI

InChI=1S/C23H26FN5O/c1-17(30)29(14-18-4-2-10-25-12-18)22-5-3-11-28(16-22)15-20-13-26-27-23(20)19-6-8-21(24)9-7-19/h2,4,6-10,12-13,22H,3,5,11,14-16H2,1H3,(H,26,27)/t22-/m0/s1

InChI Key

MTHWKTVVXWYMDC-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD32257178

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

407.49

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.646

Distribution Coefficient, logD

0.742

Water Solubility, LogSw

-1.46

Polar Surface Area

53.344

Acid Dissociation Constant (pKa)

11.67

Base Dissociation Constant (pKb)

8.25

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

34.78

SC13-0745 in Drug Discovery

Included in Screening Libraries

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with SC13-0745 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound SC13-0745?
Check Price and Availability of SC13-0745, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of SC13-0745 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for SC13-0745
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for SC13-0745
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of SC13-0745 available by request